How to buy Medibank (MPL) shares
Learn how to easily invest in Medibank shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Medibank Private Limited is an insurance-diversified business based in Australia. Medibank shares (MPL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Medibank has a trailing 12-month revenue of around $7 billion. If you're looking to buy shares, check out the steps below.
How to buy shares in Medibank
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Medibank. Find the share by name or ticker symbol: MPL. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medibank reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Medibank. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Medibank key stats
- Compare share trading platforms
- Is Medibank stock a buy or sell?
- Medibank performance over time
- Is Medibank suitable for ethical investing?
- Are Medibank shares over-valued?
- Medibank's financials
- How volatile are Medibank shares?
- Does Medibank pay a dividend?
- Other common questions
Medibank stock price (ASX:MPL)Use our graph to track the performance of MPL stocks over time.
Medibank shares at a glance
|52-week range||$2.3925 - $3.61|
|50-day moving average||$3.5322|
|200-day moving average||$3.1821|
|Dividend yield||$0.127 (3.58%)|
|Earnings per share (TTM)||$0.16|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Medibank stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Medibank price performance over time
|1 week (2021-09-17)||0.85%|
|1 month (2021-08-25)||0.56%|
|3 months (2021-06-25)||13.69%|
|6 months (2021-03-25)||22.68%|
|1 year (2020-09-25)||39.45%|
|2 years (2019-09-25)||3.78%|
|3 years (2018-09-25)||22.68%|
|5 years (2016-09-23)||41.11%|
Is Medibank under- or over-valued?
Valuing Medibank stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medibank's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medibank's P/E ratio
Medibank's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Medibank shares trade at around 22x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Medibank's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $654 million (£0.0 million).
The EBITDA is a measure of a Medibank's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$7 billion|
|Operating margin TTM||9.05%|
|Gross profit TTM||$1.5 billion|
|Return on assets TTM||10.36%|
|Return on equity TTM||23.82%|
|Market capitalisation||$9.8 billion|
TTM: trailing 12 months
Medibank's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medibank.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Medibank's total ESG risk score
Total ESG risk: 20.86
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medibank's overall score of 20.86 (as at 12/31/2018) is pretty good – landing it in it in the 29th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Medibank is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Medibank's environmental score
Environmental score: 3.11/100
Medibank's environmental score of 3.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Medibank's social score
Social score: 10.91/100
Medibank's social score of 10.91 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Medibank's governance score
Governance score: 8.84/100
Medibank's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Medibank is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Medibank's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Medibank scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Medibank has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||20.86|
|Total ESG percentile||29.38|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||2|
Medibank share dividends
Dividend payout ratio: 79.38% of net profits
Recently Medibank has paid out, on average, around 79.38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.87% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medibank shareholders could enjoy a 3.87% return on their shares, in the form of dividend payments. In Medibank's case, that would currently equate to about A$0.127 per share.
Medibank's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 September 2021 (the "ex-dividend date").
Medibank share price volatility
Over the last 12 months, Medibank's shares have ranged in value from as little as $2.3925 up to $3.61. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Medibank's is 0.3267. This would suggest that Medibank's shares are less volatile than average (for this exchange).
Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. The company operates through two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. Medibank Private Limited underwrites its health insurance products under the Medibank and ahm brands. The company was founded in 1976 and is based in Docklands, Australia.
Stocks similar to Medibank
Medibank in the news
Medibank Private : 450,000 reasons to say thanks
Medibank Private : No-gap endoscopy now available to Sydney customers
Medibank Private : Creating a sustainable future – a look back on FY21
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert